yeah agree. $5.5m not a lot, the accent trial will burn through a lot now, once you expand a trial to other countries costs ramp up quickly with a CRO running it. these CROs ain't charities and I've heard stories of them charging like wounded bulls..
//and a USA trial won't be cheap, they typically charge a lot over there, more than Europe.
//it is possible to get an IND but choose not to do a trial in US, I've heard anecdotally of companies just getting the IND for purposes of kudos having an FDA tick for your drug's profile, but then run a trial elsewhere. what I don't understand is why didn't they bolt on the folfirox /AMP combination onto Accent as a kind of parallel study, might have been more efficient and cost-effective?
- Forums
- ASX - By Stock
- ATX
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-9
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATX (ASX) to my watchlist
|
|||||
Last
9.5¢ |
Change
0.001(1.06%) |
Mkt cap ! $26.10M |
Open | High | Low | Value | Volume |
9.5¢ | 10.0¢ | 9.4¢ | $22.98K | 240.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 146804 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 52046 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 146804 | 0.095 |
1 | 95561 | 0.094 |
1 | 50000 | 0.093 |
1 | 10869 | 0.092 |
3 | 400000 | 0.091 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 149919 | 2 |
0.110 | 325 | 1 |
0.130 | 2243 | 1 |
0.140 | 173297 | 4 |
0.145 | 120000 | 3 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |